Deep sequencing as a diagnostic tool in patients with suspected primary vitreoretinal lymphoma
MDS detected pathogenic mutations in five out of six patients diagnosed with VRL, including in two patients with negative cytology, demonstrating its potential to improve diagnostic rates of VRL as an adjunctive test.
Authors
- John A. Gonzales (ORCID: https://orcid.org/0000-0003-0558-9793)
- Jill Fielding-Wells (ORCID: https://orcid.org/0000-0002-1469-4504)
- Armin Hinterwirth (ORCID: https://orcid.org/0000-0001-6450-488X)
- Thuy Doan (ORCID: https://orcid.org/0000-0003-2733-8370)
- Hans E. Grossniklaus (ORCID: https://orcid.org/0000-0003-0178-9712)
- Steven Yeh (ORCID: https://orcid.org/0000-0002-5417-7771)
- Jessica G. Shantha (ORCID: https://orcid.org/0000-0002-4449-8598)
- Charlene Choo
- Karina Bostwick
- Olivia Cote
- Matthew Regueiro
Institutions
- Cleveland Clinic (US)
- Emory University (US)
- University of California, San Francisco (US)
- San Francisco Foundation (US)
- Emory Eye Center (US)
- Cleveland Eye Clinic (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- British Journal of Ophthalmology
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1136/bjo-2023-324769
- Citations
- 1
- Primary Topic
- CNS Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Research to Prevent Blindness
- National Institutes of Health
- University of California, San Francisco
- National Eye Institute